The estimated Net Worth of Timothy P Burgess is at least $667 Tisíc dollars as of 12 April 2021. Mr. Burgess owns over 5,045 units of Lifecore Biomedical Inc stock worth over $88,870 and over the last 5 years he sold LNDC stock worth over $0. In addition, he makes $577,853 as Senior Vice President of Supply Chain for Curation Foods at Lifecore Biomedical Inc.
Timothy has made over 2 trades of the Lifecore Biomedical Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently he bought 5,045 units of LNDC stock worth $50,400 on 12 April 2021.
The largest trade he's ever made was buying 5,100 units of Lifecore Biomedical Inc stock on 31 October 2019 worth over $49,674. On average, Timothy trades about 2,029 units every 106 days since 2019. As of 12 April 2021 he still owns at least 10,145 units of Lifecore Biomedical Inc stock.
You can see the complete history of Mr. Burgess stock trades at the bottom of the page.
Timothy (Tim) P. Burgess serves as Senior Vice President of Supply Chain for Curation Foods of the Company. Prior to joining Curation Foods, Mr. Burgess was Vice President Global Manufacturing from February 2018 until March 2019 at Trident Seafood, the largest privately held seafood company in the United States. From March 2006 to February 2018 Mr. Burgess served as Vice President of Supply Chain APAC for Mead Johnson Nutrition, a pediatric nutrition company based in Singapore. Earlier in his career Mr. Burgess was plant manager for Dannon and Basic Vegetable Products.
As the Senior Vice President of Supply Chain for Curation Foods of Lifecore Biomedical Inc, the total compensation of Timothy Burgess at Lifecore Biomedical Inc is $577,853. There are 4 executives at Lifecore Biomedical Inc getting paid more, with Dr. Albert D. Bolles Ph.D. having the highest compensation of $989,459.
Timothy Burgess is 57, he's been the Senior Vice President of Supply Chain for Curation Foods of Lifecore Biomedical Inc since 2019. There are 14 older and 4 younger executives at Lifecore Biomedical Inc. The oldest executive at Lifecore Biomedical Inc is Charles Macaluso, 76, who is the Independent Director.
Timothy's mailing address filed with the SEC is C/O LANDEC CORPORATION, 2811 AIRPARK DRIVE, SANTA MARIA, CA, 93455.
Over the last 21 years, insiders at Lifecore Biomedical Inc have traded over $49,493,033 worth of Lifecore Biomedical Inc stock and bought 1,245,307 units worth $12,385,872 . The most active insiders traders include Nicholas Tompkins, Partners Small Cap Value Lp... a Gary T Steele. On average, Lifecore Biomedical Inc executives and independent directors trade stock every 17 days with the average trade being worth of $253,944. The most recent stock trade was executed by Partners Small Cap Value Lp... on 24 October 2022, trading 250,000 units of LNDC stock currently worth $2,022,500.
Landec Corporation is a leading innovator of diversified health and wellness solutions with two operating businesses: Curation Foods, Inc. and Lifecore Biomedical, Inc.Landec designs, develops, manufactures and sells products for the food and biopharmaceutical industry. Curation Foods is focused on innovating and distributing plant-based foods with 100% clean ingredients to retail, club and foodservice channels throughout North America. Curation Foods is able to maximize product freshness through its geographically dispersed family of growers, refrigerated supply chain and patented BreatheWay® packaging technology. Curation Foods brands include Eat Smart® fresh packaged vegetables and salads, O Olive Oil & Vinegar® premium artisan products and Yucatan® and Cabo Fresh® avocado products. Lifecore Biomedical is a fully integrated contract development and manufacturing organization (CDMO) that offers highly differentiated capabilities in the development, fill and finish of sterile injectable pharmaceutical products in syringes and vials. As a leading manufacturer of premium, injectable grade Hyaluronic Acid, Lifecore brings 35 years of expertise as a partner for global and emerging biopharmaceutical and biotechnology companies across multiple therapeutic categories to bring their innovations to market.
Lifecore Biomedical Inc executives and other stock owners filed with the SEC include: